Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 245 adverse event reports in the FDA FAERS database where PEGFILGRASTIM was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for PEGFILGRASTIM

Side Effect Reports % Deaths Hosp.
Device adhesion issue 11,326 14.0% 9 12
Wrong technique in product usage process 10,217 12.6% 13 80
Unintentional medical device removal 8,882 11.0% 7 23
Device malfunction 6,818 8.4% 3 53
Device use error 6,001 7.4% 4 20
Device issue 5,071 6.3% 7 48
Accidental exposure to product 4,967 6.1% 1 13
Device occlusion 3,239 4.0% 3 13
Off label use 3,228 4.0% 140 299
Bone pain 2,266 2.8% 48 421
Febrile neutropenia 2,154 2.7% 237 1,203
Drug dose omission 2,089 2.6% 3 52
Drug dose omission by device 2,051 2.5% 3 26
Neutropenia 1,863 2.3% 163 659
Intercepted product preparation error 1,514 1.9% 1 1

Other Indications for PEGFILGRASTIM

Product used for unknown indication (43,274) Neutropenia (21,342) Prophylaxis (7,424) Breast cancer (813) B-cell lymphoma (774) Colony stimulating factor therapy (692) Breast cancer female (635) Febrile neutropenia (492) Colony stimulating factor prophylaxis (436) Agranulocytosis (272)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

PEGFILGRASTIM Full Profile All Diffuse large b-cell lymphoma Drugs PEGFILGRASTIM Demographics PEGFILGRASTIM Timeline